Table 1

Patient response, survival time, and tumor staining characteristics in biochemotherapy protocol

Patient characteristicsImmunohistochemistry
Patient no.ResponseSurvival time (mo)aStatusiNOSNT
First diagnosisbFirst treatment daycPretreatmentPosttreatment
1Rd179DOD+++++
2NR2014DODN/A++++
3R3332DODN/A++++
4NR2117DOD+
5NR5918DOD+++++++
6R?19DODN/A++++
7NR4022DODN/A+++
8NR2928DODN/A+
9NR2625DOD+++++
10NR3029DOD++++++++
11NR6744DODN/A++++
12NR?48DODN/A
15R54+53+ANEDN/A
16NR74+56+AWD
13NR72+61+AWD
14NR74+61+ANEDN/A
20R69+60+ANED
17R99+65+ANEDN/A
19NR?65+ANED
18R92+66+ANED++++++++
  • a–c Survival measured from:

  • b the date of primary tumor diagnosis, and

  • c the initiation of treatment.

  • d R, major response; NR, absence of major response; DOD, dead of disease; ANED, alive with no evidence of disease; AWD, alive with disease; N/A, not available; ?, not known.